Transcription of NHSN Biovigilance Component Protocol
{{id}} {{{paragraph}}}
Example: stock market
NHSN Biovigilance Component Protocol
NHSN Biovigilance Component Hemovigilance Module Surveillance Protocol Page 1 of 30 April 2018 National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention Atlanta, GA, USA NHSN Biovigilance Component Hemovigilance Module Surveillance Protocol Page 2 of 30 April 2018 Version History Version Release Date Summary of Revisions March 2009 First version publicly released. June 2010 Revised background and text in main body of document. Revised case definition criterion based on WG recommendations, pilot responses, and CDC recommendations. Updated FNHTR definition to allow reaction without documented fever. Defined hypotension for infants and small children Clarified TAGVHD probable and possible criteria.
October of 2013, report information for January 2012-December 2012 on the first Hemovigilance Module Annual Facility Survey. In January 2014, complete a new survey with data from January 2013-December 2013. CDC recommends collecting all survey information on a paper form before attempting to enter data into the web application.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: